Britain's AstraZeneca has received regulatory approval to conduct part of a Phase Three trial of its potential Covid-19 vaccine in Russia, a filing in the Russian registry of clinical trials showed on Friday.
[MOSCOW] Britain's AstraZeneca has received regulatory approval to conduct part of a Phase Three trial of its potential Covid-19 vaccine in Russia, a filing in the Russian registry of clinical trials showed on Friday.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: